Stereotaxis (STXS) Research & Development (2010 - 2026)

Stereotaxis (STXS) has 17 years of Research & Development data on file, last reported at $2.6 million in Q1 2026.

• On a quarterly basis, Research & Development fell 16.87% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $14.2 million, a 5.34% decrease from a year earlier, with the FY2025 full-year figure at $12.4 million, up 0.57% from the prior year.
• Research & Development for Q1 2026 stood at $2.6 million, down from $5.8 million in the prior quarter.
• Over the last five years, Research & Development for STXS reached as high as $5.8 million in Q4 2025 and fell as low as $688000.0 in Q4 2023.
• Historically, Research & Development has averaged $3.1 million across 5 years, with a median of $3.1 million in 2022.
• Across the five-year window, Research & Development tumbled 71.33% in 2023 and jumped 685.17% in 2024, its largest moves.
• Year by year, Research & Development stood at $2.4 million in 2022, then tumbled by 71.33% to $688000.0 in 2023, then soared by 685.17% to $5.4 million in 2024, then advanced by 6.81% to $5.8 million in 2025, then slumped by 54.64% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $2.6 million in Q1 2026, $5.8 million in Q4 2025, and $2.5 million in Q3 2025.